Biliary reflux gastritis: features of pathogenesis, diagnostics and treatment
https://doi.org/10.30629/0023-2149-2023-101-7-8-404-409
Abstract
The article discusses the controversial terminology of biliary refl ux gastritis and the factors predisposing to its occurrence. Pathogenesis of this disease includes 2 main components: disorders of motility of the stomach and duodenum, leading to duodeno-gastric refl ux, and direct damaging eff ect of hydrophobic bile acids and lysolecithin on the protective barrier of the stomach mucosa. Clinical picture of biliary refl ux gastritis is nonspecifi c and most often corresponds to dyspepsia syndrome. Esophagogastroduodenoscopy with biopsy and subsequent histological examination, 24-hour pH-metry of the stomach, monitoring of bilirubin level in gastric contents are used in diagnostics of this disease. Treatment of biliary refl ux gastritis includes prescription of ursodeoxycholic acid, prokinetics, antacids, proton pump inhibitors, cytoprotectors. Given the insuffi cient study and controversial coverage of many aspects of biliary refl ux gastritis, this problem requires further research.
About the Authors
A. A. SheptulinRussian Federation
119991, Moscow
O. A. Storonova
Russian Federation
119991, Moscow
P. V. Pavlov
Russian Federation
119991, Moscow
A. S. Tertychny
Russian Federation
119991, Moscow
D. D. Protsenko
Russian Federation
119991, Moscow
X. V. Feoktistova
Russian Federation
119991, Moscow
References
1. Shi X., Chen Z., Yang Y., Yan S. Bile reflux gastritis: insights into pathogenesis, relevant factors, carcinomatous risk, diagnosis, and management. Gastroenterol. Res. Pract. 2022;2022:2642551. DOI: 10.1155/2022/2642551
2. Lee E.L., Feldman M. Gastritis and other gastropathies. In: Sleisenger & Fordtran’s Gastrointestinal and Liver Disease (Ed. Feldman M. et al.), 7th edition. 2002;1:810–821.
3. Misiewicz J.J, Tytgat G.N.Y., Goodwin C.S. et al. The Sydney system: a new classifi cation of gastritis. 9th Congress of Gastroenterology. Working party reports. Blackwell-Melburne. 1990:1–10.
4. Ivashkin V.T., Sheptulin A.A. Diseases of esophagus, stomach and intestinum. MEDpress-inform, 2009:176. (In Russian).
5. Aruin L.I., Grigiriev P.Ja., Isakov V.A. Jakovenko E.P. Chronic gastritis, Amsterdam, 1993:362. (In Russian).
6. Sugano K., Tack J., Kuipers E.J., Graham D., El-Omar E., Miura S. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015:64(9):1353–67. DOI: 10.1136/gutjnl-2015-309252
7. Minushkin O.N., Zverkov I.V., Lvova N.V. Skibina Ju.S, Inevatova V.S. Chronic gastritis: modern state of the problem. Therapeutic Archive. 2020;92(8):18–23. (In Russian). DOI: 10.26442/0040366.2020.08.000693
8. Sakaguchi T., Sugihara T., Ohnita K., Fukuda D., Honda T., Ogihara R. et al. Pyloric incompetence associated with Helicobacter pylori infection and correlated to the severity of atrophic gastritis. Diagnostics (Basel). 2022;12(3):572. DOI: 10.3390/diagnostics12030572
9. Zhuo X.H., Sun J.C., Zhong W.J., Lu Y. Negative correlations between bile reflux gastritis and Helicobacter pylori infection. Scand. J. Gastroenterol. 2022;57(12):1430–1434. DOI: 10.1080/00365521.2022.2094721
10. Livzan M.A., Mozgovoi S.I., Gaus O.V., Bordin D.S., Kononov A.V. Diagnostic principles for chronic gastritis associated with duodenogastric reflux. Diagnostics (Basel). 2023;13(2):186. DOI: 10.3390/diagnostics13020186
11. Gastritis and peptic ulcer disease. In: The Merck Manual (Ed. Beers M.H. et al.), 18th Edition. 2006:115–128.
12. Li D., Zhang L., Yao W.Z., Zhang D.L., Feng C.C., He Q. et al. The relationship between gastric cancer, its precancerous lesions and bile reflux: A retrospective study. J. Dig. Dis. 2020;21(4):222–229. DOI: 10.1111/1751-2980.12858
13. Chen L., Zhu G., She L., Ding Y., Yang C., Zhu F. Analysis of risk factors and establishment of a prediction model for endoscopic primary bile reflux: A single-center retrospective study. Front Med. (Lausanne). 2021;8:758771. DOI: 10.3389/fmed.2021.758771
14. Vere C.C., Cazacu S., Comanescu V., Mogoanta L., Rogoveanu I., Ciurea T. Endoscopical and histological features in bile reflux gastritis. Rom. J. Morphol. Embryol. 2005;46(4):269–274.
15. Mercan E., Duman U., Tihan D., Dilektasli E., Senol K. Cholecystectomy and duodenogastric reflux: interacting effects over the gastric mucosa. Springerplus. 2016;5(1):1970. DOI: 10.1186/s40064-016-3641-z
16. Sobala G.M., King R.F., Axon A.T., Dixon M.F. Reflux gastritis in the intact stomach. J. Clin. Pathol. 1990;43(4):303–336. DOI: 10.1136/jcp.43.4.303
17. Gastritis. In: Gastroenterology systematisch (Hrsg. Göke B., Beglinger Ch.), 2. Auflage. Bremen. 2007:141–149.
18. Shi Y., Wei Y., Zhang T., Zhang J., Wang Y., Ding S. Deoxycholic acid could induce apoptosis and trigger gastric сarcinogenesis on gastric epithelial cells by quantitative proteomic analysis. Gastroenterol. Res. Pract. 2016;2016:9638963. DOI: 10.1155/2016/9638963
19. Dixon M.F., O’Connor H.J., Axon A.T., King R.F., Johnston D. Reflux gastritis: distinct histopathological entity? J. Clin. Pathol 1986;39(5):524–530. DOI: 10.1136/jcp.39.5.524
20. Genta R.M. Differential diagnosis of reactive gastropathy. Semin. Diagn. Pathol. 2005;22(4):273–283. DOI: 10.1053/j.semdp.2006.04.001
21. Owen D.A. Gastritis and carditis. Mod. Pathol. 2003;16(4):325–341. DOI: 10.1097/01.MP.0000062995.72390.14
22. Rugge M., Savarino E., Sbaraglia M., Bricca L., Malfertheiner P. Gastritis: The clinico-pathological spectrum. Dig. Liver. Dis. 2021;53(10):1237–1246. DOI: 10.1016/j.dld.2021.03.007
23. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classifi cation and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996;20(10):1161–1181. DOI: 10.1097/00000478-199610000-00001
24. Wolf E.M., Plieschnegger W., Geppert M., Wigginghaus B., Höss G.M., Eherer A., Schneider N.I., Hauer A., Rehak P., Vieth M., Langner C. Changing prevalence patterns in endoscopic and histological diagnosis of gastritis? Data from a cross-sectional CentralEuropean multicentre study. Dig. Liver. Dis. 2014;46(5):412–418. DOI: 10.1016/j.dld.2013.12.017
25. Sobala G.M., O’Connor H.J., Dewar E.P., King R.F., Axon A.T., Dixon M.F. Bile reflux and intestinal metaplasia in gastric mucosa. J. Clin. Pathol. 1993;46(3):235–240. DOI: 10.1136/jcp.46.3.235
26. Matsuhisa T., Arakawa T., Watanabe T., Tokutomi T., Sakurai K., Okamura S., Chono S., Kamada T., Sugiyama A., Fujimura Y. et al. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: A multicenter study of 2283 cases. Dig. Endosc. 2013;25:519–525. DOI: 10.1111/den.12030
27. He Q., Liu L., Wei J., Jiang J., Rong Z., Chen X. et al. Roles and action mechanisms of bile acid-induced gastric intestinal metaplasia: A review. Cell Death. Discov. 2022;8:158. DOI: 10.1038/s41420-022-00962-1
28. Lake A., Rao SS C., Larion S., Spartz H., Kavuri S. Bile reflux gastropathy and functional dyspepsia. J. Neurogastroenterol. Motil. 2021;27:400–407. DOI: 10.5056/jnm20102
29. Kunsch S., Neesse A., Linhart T., Nell C., Gress T.M., Ellenrieder V. Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy. Digestion. 2012;86:315–322. DOI: 10.1159/000342234
30. Chen T.-F., Ydav P.K., Wu R.-J., Yu W.-H., Liu C.-Q., Lin H., Liu Z.-J. Comparative evaluation of intragastric bile acids and hepatobiliary scintigraphy in the diagnosis of duodenogastric reflux. World J. Gastroenterol. 2013;19(14):2187–96. DOI: 10.3748/wjg.v19.i14.2187
31. Zubarev A.P. Optimization of diagnosis and treatment of patients with acute cholecystitis with duodenogastric reflux in the perioperative period. Sinopsis of Diss. Cand. Med. Sciences. Ulynovsk. 2015:24 p. (In Russian).
32. Ivashkin V.T. The signifi cance of radiotelemetric studies of intragastric and intraduodenal pH for evaluating the effectiveness of antacids and atropine in patients with chronic diseases of the stomach and duodenum. Diss. Cand. Med. Sciences. L., 1970:187 p. (In Russian). Iv
33. Chen H., Li X., Ge Z., Gao Y., Chen X., Cui Y. Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy. Can. J. Gastroenterol. 2010;24(3):197–201. DOI: 10.1155/2010/846353
34. Tel’nykh. Yu.V., Abgadzhva E.Z., Kon’kov Yu.V. Biliary reflux-gastritis: etiology, pathogenesis and modern principles of treatment. Clin. Med. 2016;94(6):454–457. (In Russian). DOI: 10.18821/0023-2149-2016-94-6-454-457
35. Santarelli L., Gabrielli M., Candelli M., Cremonini F., Nista E.K., Cammarota G. et al. Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment. Eur. J. Gastroenterol. Hepatol. 2003;15(9):975–979. DOI: 10.1097/00042737-200309000-00006
36. Ozkaya M., Erten A, Sahin I., Engin B., Ciftci A., Cakal E. et al. The effect of ursodeoxycholic acid treatment on epidermal growth factor in patients with bile reflux gastritis. Turk. J. Gastroenterol. 2003;13(4):198–202.
Review
For citations:
Sheptulin A.A., Storonova O.A., Pavlov P.V., Tertychny A.S., Protsenko D.D., Feoktistova X.V. Biliary reflux gastritis: features of pathogenesis, diagnostics and treatment. Clinical Medicine (Russian Journal). 2023;101(7-8):404-409. (In Russ.) https://doi.org/10.30629/0023-2149-2023-101-7-8-404-409